Novel therapies in managing Allergic rhinitis: How far have we come? Dr. Kamal Kant Kohli8 Jun 2022 12:45 PM ISTAllergic rhinitis(AR) is a common respiratory condition affecting 40 % of the worldwide population. Due to its shared pathophysiology with...
Understanding the scope of Faropenem in Lower Respiratory Tract Infections(LRTIs) Dr. Kamal Kant Kohli1 Jun 2022 11:03 AM ISTLower Respiratory Infections(LRIs): Complexities in the Indian ContextIn India, the burden of lower respiratory tract infections (LRTIs) is...
Decoding the Management of Otitis Media and Role of Amoxicillin Dr. Kamal Kant Kohli27 May 2022 12:30 PM ISTAcute otitis media (AOM) - an infection of the middle ear, is the second most common pediatric diagnosis in the primary and emergency care department...
Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection Dr. Kamal Kant Kohli19 May 2022 12:54 PM ISTThe spiking frequency of allergic respiratory illness over the last several decades, and the increasing rate of air pollution owing to urbanization,...
Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin? Dr.Pankaj P. Changedia14 May 2022 12:30 PM ISTEver since the introduction of antimicrobial agents, there has been an association between antibiotic use and the development of antimicrobial...
Analyzing the efficacy and safety of leukotriene receptor antagonists in the management of allergic rhinitis Dr. Kamal Kant Kohli29 April 2022 12:00 PM ISTAllergic Rhinitis (AR) is an inflammatory illness of the upper respiratory tract, with sneezing, itching, nasal congestion, and rhinorrhea as the most...
Respiratory Allergic Affections: Management in India and Therapeutic Effect of Montelukast Dr. Kamal Kant Kohli22 April 2022 10:00 AM ISTAllergic diseases have turned into a major health concern around the world, with India being no exemption. Purportedly, over 25% of the total...
Review: Patient preferences for Intranasal Corticosteroids on account of Sensory Attributes Dr. Kamal Kant Kohli11 April 2022 9:00 AM ISTIntranasal corticosteroids are the pillar treatment for allergic rhinitis, a broad disease that affects over 500 million people around the world...
Casirivimab and imdevimab in patients admitted to hospital with COVID-19: RECOVERY Trial Dr. Kamal Kant Kohli9 March 2022 5:19 PM ISTCasirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor-binding domain of the SARS-CoV-2...
Quick Review: Diagnosis and management of allergic rhinitis in clinic Dr. Kamal Kant Kohli9 March 2022 12:30 PM ISTAllergic Rhinitis is one of the common conditions for which medical intervention is sought and is a leading cause of widespread morbidity. At a global...
Review: Intranasal corticosteroids in Allergic rhinitis Dr. Kamal Kant Kohli28 Feb 2022 11:54 AM ISTAllergic Rhinitis is one of the most common persistent conditions for which clinical intervention is sought and is a significant cause of widespread...
Decoding safety, tolerability, and pharmacokinetics of Molnupiravir Dr. Kamal Kant Kohli4 Feb 2022 11:56 AM ISTMolnupiravir is a prodrug of active antiviral ribonucleoside analog b-D-N4-hydroxycytidine (NHC; EIDD-1931), with the potential to treat infections...
